Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003770 |
---|---|
Receipt number | R000004565 |
Scientific Title | A Phase II study of Pemetrexed plus Carboplatin Plus Bevacizumab followed by maintenance Pemetrexed Plus Bevacizumab in patients with previously untreated stage III/IV or post-operative recurrent non-squamous non-small-cell and lung cancer. |
Date of disclosure of the study information | 2010/06/21 |
Last modified on | 2013/06/17 09:25:38 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/06/17 11:14:00 | ||
2 | Update | 2011/12/20 09:56:19 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2013/06/17 09:25:38 | Recruitment status |